Updated Jul 16, 2026
Sabba Stephen L has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.16M.
Stephen L. Sabba is a corporate executive known for his role as a Director at Ligand Pharmaceuticals Inc. His contributions to the company are primarily in governance and strategic oversight. Further details about his career and achievements are not widely documented in public sources.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 2.1K | $254.00 | $545K |
| 2026-06-18 | LGND | LIGAND PHARMACEUTICALS INC | M — Option exercise | 2.1K | $66.13 | $142K |
| 2026-06-09 | LGND | LIGAND PHARMACEUTICALS INC | A — Grant or award | 836 | $0.00 | |
| 2026-03-25 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 1.0K | $207.87 | $208K |
| 2026-03-05 | LGND | LIGAND PHARMACEUTICALS INC | S — Open-market sale | 2.0K | $201.50 | $410K |
| 2026-03-05 | LGND | LIGAND PHARMACEUTICALS INC | M — Option exercise | 2.0K | $69.51 | $141K |
Stephen L. Sabba is a corporate executive known for his role as a Director at Ligand Pharmaceuticals Inc. His contributions to the company are primarily in governance and strategic oversight. Further details about his career and achievements are not widely documented in public sources.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($1.16M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sabba Stephen L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.